Five common gene variants identify elevated genetic risk for coronary heart disease

被引:77
作者
Bare, Lance A.
Morrison, Alanna C.
Rowland, Charles M.
Shiffman, Dov
Luke, May M.
Iakoubova, Olga A.
Kane, John P.
Malloy, Mary J.
Ellis, Stephen G.
Pankow, James S.
Willerson, James T.
Devlin, James J.
Boerwinkle, Eric
机构
[1] Celera, Alameda, CA 94502 USA
[2] Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA
[3] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[4] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA
[5] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA
[6] Texas Heart Inst, Inst Mol Med, Houston, TX 77025 USA
关键词
atherosclerosis risk in communities study; coronaty heart disease; genetic risk score; variant; single nucleotide polymorphism; complex disease;
D O I
10.1097/GIM.0b013e318156fb62
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: Because multiple genetic variants influence risk for coronary heart disease, we combined multiple variants that had been associated with coronary heart disease in several studies into a genetic risk score and asked whether a high genetic risk score would be significantly associated with coronary heart disease after accounting for traditional risk factors. Methods: We considered five variants that were associated with coronary heart disease in two studies and confirmed in the Atherosclerosis Risk in Communities study: rs20455 (KIF6), rs3900940 (MYH15), rs7439293 (PALLD), rs2298566 (SNX19), and rs1010 (VAMP8). We calculated a genetic risk score for each Atherosclerosis Risk in Communities study participant and estimated the hazard ratio for incident coronary heart disease of a high genetic risk score (compared with not-high) in Cox models that adjusted for traditional risk factors during a median of 13 years of follow-up. Results: For white participants with a high genetic risk score (4% of the 9129 whites), compared with those without a high genetic risk score, the hazard ratio for incident coronary heart disease was 1.57 (95% confidence interval 1.21-2.04; P = 0.001). Internal validation using bootstrap samples estimated that a hazard ratio of 1.43 could be expected in external populations. Conclusions: After adjusting for traditional risk factors, those with a high genetic risk score had a 57% increased risk of incident coronary heart disease in the Atherosclerosis Risk in Communities study.
引用
收藏
页码:682 / 689
页数:8
相关论文
共 34 条
  • [1] Preventing myocardial infarction in the young adult in the first place: How do the National Cholesterol Education Panel III guidelines perform?
    Akosah, KO
    Schaper, A
    Cogbill, C
    Schoenfeld, P
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (09) : 1475 - 1479
  • [2] [Anonymous], 2005, SURVIV ANAL, DOI DOI 10.1007/0-387-29150-4_3
  • [3] A tutorial on statistical methods for population association studies
    Balding, David J.
    [J]. NATURE REVIEWS GENETICS, 2006, 7 (10) : 781 - 791
  • [4] Investigating the genetic determinants of cardiovascular disease using candidate genes and meta-analysis of association studies
    Casas, JP
    Cooper, J
    Miller, GJ
    Hingorani, AD
    Humphries, SE
    [J]. ANNALS OF HUMAN GENETICS, 2006, 70 : 145 - 169
  • [5] COX DR, 1972, J R STAT SOC B, V34, P187
  • [6] An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers - The atherosclerosis risk in communities study
    Folsom, Aaron R.
    Chambless, Lloyd E.
    Ballantyne, Christie M.
    Coresh, Josef
    Heiss, Gerardo
    Wu, Kenneth K.
    Boerwinkle, Eric
    Mosley, Thomas H., Jr.
    Sorlie, Paul
    Diao, Guoqing
    Sharrett, A. Richey
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (13) : 1368 - 1373
  • [7] Metabolic syndrome: Connecting and reconciling cardiovascular and diabetes worlds
    Grundy, SM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (06) : 1093 - 1100
  • [8] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, R
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Cleeman, JI
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    Keller, SA
    Jehle, AJ
    [J]. CIRCULATION, 2002, 106 (25) : 3143 - 3421
  • [9] Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
    Grundy, SM
    Cleeman, JI
    Merz, CNB
    Brewer, HB
    Clark, LT
    Hunninghake, DB
    Pasternak, RC
    Smith, SC
    Stone, NJ
    [J]. CIRCULATION, 2004, 110 (02) : 227 - 239
  • [10] Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO